Pharmaceutical

STAT+: STAT-Harris Poll: Most Americans are worried abo...

More than two-thirds of people in the U.S. who know about RSV said they're worri...

STAT+: Pharmalittle: GSK manufacturing workers in the U...

Hundreds of GSK workers have voted to stage a series of walkouts at U.K. manufac...

STAT+: Relay’s breast cancer drug proves tolerable, but...

A drug by Relay Therapeutics shows it can attack breast cancer cells without cau...

STAT+: Leaked study results show a CAR-T from J&J provi...

The CAR-T cancer therapy called Carvykti reduced the risk of relapse by 74% comp...

Discrimination lawsuit against HHMI spotlights barriers...

After Vivian Cheung developed a genetic condition that caused her to start losin...

STAT+: Mindpath seemed like a success story for private...

A STAT investigation of private equity-owned Mindpath Health uncovered a range o...

Opinion: RSV vaccine approval should be a top priority ...

Regulators are considering two highly effective RSV vaccines. What's the holdup?

Opinion: The window is closing to stop deadly drug-resi...

Look to tulip production in the Netherlands for a cautionary tale on the overuse...

STAT+: Mark Cuban’s drug company creates a pharmacy net...

In its latest bid to upend the pharmaceutical supply chain, the Mark Cuban Cost ...

STAT+: Novel strategy of attacking sugars on cancer cel...

A new kind of chemistry, which won the Nobel Prize, gets its first test as a pos...

FDA says older adults and the immunocompromised may get...

People ages 65 and older and those who are immunocompromised will be allowed to ...

Opinion: Where are the guidelines for the production of...

Realizing the benefits of animals with intentional genomic alterations depends o...

STAT+: A bellwether moment: Once a distant dream, gene ...

For Sarepta, an experimental gene therapy is a story of foresight, savvy dealmak...

STAT+: Moderna-Merck mRNA cancer vaccine shows promise ...

New results involving a Moderna-Merck mRNA vaccine provides the strongest confir...

STAT+: Merck to acquire Prometheus Biosciences, maker o...

For Merck, acquiring Prometheus bolsters its research pipeline and introduces ne...

STAT+: Supreme Court pauses new limits on abortion pill...

Access to the abortion pill mifepristone will remain unchanged until next Wednes...